Canada Life
STOK icon

Canada Life’s Stoke Therapeutics STOK Stock Holding History

Canada Life’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$824K Buy
25,197
+6,367
+34% +$204K ﹤0.01% 1417
2026
Q1 		$613K Buy
18,830
+4,062
+28% +$133K ﹤0.01% 1458
2025
Q4 		$469K Buy
14,768
+2,790
+23% +$83.9K ﹤0.01% 1522
2025
Q3 		$296K Buy
11,978
+1,313
+12% +$22.5K ﹤0.01% 1663
2025
Q2 		$121K Sell
10,665
-224
-2% -$2.13K ﹤0.01% 1746
2025
Q1 		$73K Buy
10,889
+1,173
+12% +$10.9K ﹤0.01% 1822
2024
Q4 		$107K Sell
9,716
-1,633
-14% -$20.1K ﹤0.01% 1804
2024
Q3 		$140K Buy
11,349
+1,306
+13% +$18.5K ﹤0.01% 1814
2024
Q2 		$135K Buy
10,043
+7,607
+312% +$103K ﹤0.01% 1845
2024
Q1 		$33K Buy
2,436
+326
+15% +$1.98K ﹤0.01% 2050
2023
Q4 		$11K Sell
2,110
-858
-29% -$3.67K ﹤0.01% 2153
2023
Q3 		$12K Hold
2,968
– – ﹤0.01% 2200
2023
Q2 		$32K Sell
2,968
-419
-12% -$4.46K ﹤0.01% 2063
2023
Q1 		$28K Buy
3,387
+1,078
+47% +$9.73K ﹤0.01% 2158
2022
Q4 		$21K Buy
2,309
+476
+26% +$4.95K ﹤0.01% 2251
2022
Q3 		$24K Buy
1,833
+280
+18% +$4.46K ﹤0.01% 2237
2022
Q2 		$21K Buy
1,553
+325
+26% +$4.94K ﹤0.01% 2255
2022
Q1 		$27K Buy
1,228
+248
+25% +$4.97K ﹤0.01% 2303
2021
Q4 		$24K Buy
980
+237
+32% +$5.66K ﹤0.01% 2342
2021
Q3 		$19K Hold
743
– – ﹤0.01% 2445
2021
Q2 		$25K Hold
743
– – ﹤0.01% 2442
2021
Q1 		$29K Hold
743
– – ﹤0.01% 2451
2020
Q4 		$46K Hold
743
– – ﹤0.01% 2309
2020
Q3 		$25K Hold
743
– – ﹤0.01% 2391
2020
Q2 		$18K Hold
743
– – ﹤0.01% 2512
2020
Q1 		$17K Hold
743
– – ﹤0.01% 2414
2019
Q4 		$21K Buy
+743
New +$18.7K ﹤0.01% 2489

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Life's STOK Position: Q2 2026 in Review

Canada Life increased its Stoke Therapeutics (STOK) stake by 34% in Q2 2026, buying an estimated $204K and bringing the position to 25,197 shares worth $824K. The position accounts for ﹤0.01% of the portfolio, ranked #1417.

Canada Life first reported a position in STOK in Q4 2019 and has held it in 27 quarters since. 198 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Canada Life held 25,197 shares of Stoke Therapeutics worth $824K as of Q2 2026.
  • Canada Life bought 6,367 Stoke Therapeutics shares in Q2 2026, an estimated $204K.
  • Stoke Therapeutics made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1417 holding.
  • Canada Life first reported a position in Stoke Therapeutics in Q4 2019 and has held it in 27 quarters since.
  • 198 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.